Walmart-owned Flipkart has entered into e-pharmacy space.

It has partnered with Gurgaon-primarily based 1MG, whose app is now to be had on Flipkart’s Android app. This approach customers can order prescription medicines, book medical doctor consultations and lab checks inside Flipkart.

The e-tailer’s access in e-pharmacy is already seeing opposition. The All India Organisation of Chemists and Druggists (AIOCD), a frame with 8.5 lakh members, has written to Flipkart CEO Kalyan Krishnamurthy and Walmart president & CEO Doug McMillon, pronouncing the partnership is towards nearby laws.

TOI first said ultimate month that the nearby e-commerce arm of the US-primarily based retail major was trying to input the gap amid action from Reliance, which received a 60% stake in Netmeds.

While Flipkart has now added 1MG onto its platform, it’s been constructing its very own crew internally for the e-pharmacy enterprise and held comparable partnership talks with PharmEasy, that’s obtaining smaller rival Medlife.

Owing to the site visitors it gets, Flipkart is basically looking to serve one greater customer need. Prescription medicines, lab checks and medical doctor consultations are in excessive call for amid the pandemic, as clients try to restrict their movement as much as possible.

Consumer stickiness and average order size growing to $15-20 are also a number of the motives big strategic players like Amazon, Reliance and now Flipkart are getting into the gap.

“We are forced to write to you as we discovered that Flipkart, which is owned by Walmart Inc, USA has partnered with an e-pharmacy by the name of 1MG.COM to sell ‘Prescription Medicines’ on its platform. This partnership is against the laws in our country,” AIOCD’s note to McMillon and Krishnamurthy said.

A record by market research organization RedSeer in August stated e-pharmacy platforms, which include consultation and lab checks, are predicted to clock $2 billion in gross income by March 2021, with supply chain recuperation and upward thrust in new customers.

During the pandemic, 6 million new households attempted on-line medicine, taking the total to nine million households, a current Ficci-RedSeer white paper stated. The latest RedSeer record stated e-pharmacies clocked $1.3 billion in gross income at the cease of March 2020.